Treatment approaches to major depressive disorder relapse - Part 1: Dose increase

Psychotherapy and Psychosomatics

Volumn 71, Issue 4, 2002, Pages 190-194

  Schmidt, Mark E ^a   Fava, Maurizio ^b   Zhang, Shuyu ^a   Gonzales, Jill ^a   Raute, Nancy J ^a   Judge, Rajinder ^a  

^a ELI LILLY AND COMPANY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Depression; Enteric coated fluoxetine; Long term; Relapse

Indexed keywords

FLUOXETINE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DOSE CALCULATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; ENTERIC COATED TABLET; FEMALE; HUMAN; LABORATORY TEST; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RISK; SAFETY; SCORING SYSTEM; TIME; UNITED STATES;

ADULT; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOXETINE; HUMANS; MALE; PROSPECTIVE STUDIES; RECURRENCE; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TABLETS, ENTERIC-COATED;

EID: 0036315288     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063643     Document Type: Article

References (18)

1. Treatment of major depression
2. Pharmacotherapy of depressive disorders: A consensus statement
3. Practice guidelines for major depressive disorder in adults
4. Three-year outcomes for maintenance therapies in recurrent depression
5. Strategies and tactics in the management of maintenance treatment for depressed patients
6. Loss of antidepressant efficacy during maintenance therapy: Possible mechanisms and treatments
7. Relapse in patients on long-term fluoxetine treatment: Response to increased fluoxetine dose
8. The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder
9. Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: A survey of current 'next-step' practices
10. Depressive breakthrough
11. Reducing relapse in depressed outpatients with atypical features: A pilot study
12. Management of nonresponse and intolerance: Switching strategies
13. New approaches to the treatment of refractory depression
14. Tolerance to therapeutic effects of antidepressants
15. Loss of antidepressant effect with long-term monoamine oxidase inhibitor treatment without loss of monoamine oxidase inhibition
16. Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo
17. Management of major depression in the primary care setting